0001781552-19-000003.txt : 20190712
0001781552-19-000003.hdr.sgml : 20190712
20190711213524
ACCESSION NUMBER: 0001781552-19-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190712
DATE AS OF CHANGE: 20190711
EFFECTIVENESS DATE: 20190712
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nymbl Science, Inc.
CENTRAL INDEX KEY: 0001781552
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-344117
FILM NUMBER: 19951971
BUSINESS ADDRESS:
STREET 1: 3513BRIGHTON BLVD., SUITE 478
CITY: DENVER
STATE: CO
ZIP: 80216
BUSINESS PHONE: 650-233-4548
MAIL ADDRESS:
STREET 1: 3513BRIGHTON BLVD., SUITE 478
CITY: DENVER
STATE: CO
ZIP: 80216
FORMER COMPANY:
FORMER CONFORMED NAME: Nymbl Sciences, Inc.
DATE OF NAME CHANGE: 20190703
D
1
primary_doc.xml
X0708
D
LIVE
0001781552
Nymbl Science, Inc.
3513 BRIGHTON BLVD., SUITE 478
DENVER
CO
COLORADO
80216
650-233-4548
DELAWARE
Nymbl Sciences, Inc.
Corporation
true
2018
James
Cook
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Executive Officer
Director
Promoter
Edward
Likovich
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Executive Officer
Director
Thomas
Virden
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Executive Officer
Director
Promoter
Chris
Saxman
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Director
Dr. Jean-Pierre
Farcy
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Promoter
Carol
Owens
Jones
3513 Brighton Blvd., Suite 478
Denver
CO
COLORADO
80216
Promoter
Other Technology
Decline to Disclose
- 06b
false
2019-06-27
false
true
false
10000
2675000
1970000
705000
Includes $695,000 of Series Seed-3 Preferred Stock, $505,000 of SAFEs
converted into Series Seed-1 and $770,000 into Series Seed-2 Preferred Stock, and the underlying common stock.
false
22
0
0
0
true
false
Nymbl Science, Inc.
/s/ Stephen M. Wurzburg
Stephen M. Wurzburg
Assistant Secretary
2019-07-11